In-depth Immunological Investigation of COVID-19.
The COntAGIouS trial (COvid-19 Advanced Genetic and Immunologic Sampling; an in-depth characterization of the dynamic host immune response to coronavirus SARS-CoV-2) proposes a transdisciplinary approach to identify host factors resulting in hyper-susceptibility to SARS-CoV-2 infection, which is urgently needed for dir
| Condition(s) | Coronavirus Infections |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The COntAGIouS trial (COvid-19 Advanced Genetic and Immunologic Sampling; an in-depth characterization of the dynamic host immune response to coronavirus SARS-CoV-2) proposes a transdisciplinary approach to identify host factors resulting in hyper-susceptibility to SARS-CoV-2 infection, which is urgently needed for directed medical interventions. |
| Who can participate | Inclusion Criteria: * Patients \>/= 18 years old AND * Hospitalised with PCR-confirmed and/or CT-confirmed SARS-CoV-2 disease Exclusion Criteria: * Age \< 18 years old * No informed consent |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven |
| Locations | Leuven, Belgium |
| Start date | 2020-03-27 |
| NCT ID | NCT04327570 |
| Official listing | https://clinicaltrials.gov/study/NCT04327570 |